Position in NTRA
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$493,496
+$136,714 QoQ
Shares Held
1,818
+1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#534
of 844 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026YOUSIF CAPITAL MANAGEMENT, LLC holds $70,009,977 across 19 Diagnostics & Research names. NTRA ranks #18 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
33,508 | $16,799,570 | |
| 2 | DHR |
Danaher Corp /De/
|
59,624 | $11,357,179 | |
| 3 | ILMN |
Illumina, Inc.
|
36,091 | $6,345,880 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
10,465 | $5,509,194 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
19,235 | $3,716,586 | |
| 6 | A |
Agilent Technologies, Inc.
|
26,480 | $3,517,338 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
6,276 | $3,323,706 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
2,558 | $3,267,870 |
All Filings in NTRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $493,496 | 1,818 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $356,782 | 1,784 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $391,056 | 1,707 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $270,751 | 1,682 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $271,993 | 1,610 | Shares | Sole | 2025-07-25 | |
| 2024-12-31 | $206,739 | 1,306 | Shares | Sole | 2025-01-27 | |
| No filing history on record for this holder in this stock. | ||||||